Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
Open Access
- 1 September 1998
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 41 (9), 1591-1602
- https://doi.org/10.1002/1529-0131(199809)41:9<1591::aid-art9>3.0.co;2-j
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tractsGastroenterology, 1996
- Prostaglandin Endoperoxide H Synthases-1 and -2Advances in Immunology, 1996
- Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic HemostasisThe Journal of Clinical Pharmacology, 1995
- Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.Proceedings of the National Academy of Sciences, 1994
- Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory DrugsAnnals of Internal Medicine, 1991
- Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.Proceedings of the National Academy of Sciences, 1991
- ARACHIDONIC ACID METABOLISMAnnual Review of Biochemistry, 1986
- The Role of Arachidonic Acid Oxygenation Products in Pain and InflammationAnnual Review of Immunology, 1984